Bristol-Myers Squibb To Buy Amylin Pharma For $5.3 BlnReported by FinanzNachrichten.de on Saturday, 30 June 2012 (on June 30, 2012)
|
 LONDON (dpa-AFX) - Bristol-Myers Squibb Co. (BMY) has agreed to acquire Amylin Pharmaceuticals, Inc. (AMLN) for $31 per share in cash, pursuant to a cash tender offer and second step me...
Links: Full news story
|
|
|
| Recent related news |
| No similar news headlines found. | | |
|
|